Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmine Foo

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
JCO Clinical Cancer Informatics|February 14, 2019
Glioblastoma Recurrence and the Role of O<sup>6</sup>-Methylguanine-DNA Methyltransferase Promoter MethylationKatie Storey, Kevin Leder, Andrea Hawkins-Daarud, et al.
Molecular Pharmaceutics|October 15, 2011
Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancerShannon M Mumenthaler, Jasmine Foo, Kevin Leder, et al.
Plos Computational Biology|August 2, 2024
Understanding patient-derived tumor organoid growth through an integrated imaging and mathematical modeling frameworkEinar Bjarki Gunnarsson, Seungil Kim, Brandon Choi, et al.
RNA Biology|September 22, 2012
Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAsJingmin Shu, Zhilian Xia, Lihua Li, et al.
Cancer Informatics|August 6, 2015
The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer CellsShannon M Mumenthaler, Jasmine Foo, Nathan C Choi, et al.
Scientific Reports|July 26, 2016
A high-content image-based method for quantitatively studying context-dependent cell population dynamicsColleen M Garvey, Erin Spiller, Danika Lindsay, et al.
Plos Computational Biology|July 7, 2017
Combination therapeutics of Nilotinib and radiation in acute lymphoblastic leukemia as an effective method against drug-resistanceKamran Kaveh, Yutaka Takahashi, Michael A Farrar, et al.
Plos Computational Biology|March 6, 2024
Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening dataChenyu Wu, Einar Bjarki Gunnarsson, Even Moa Myklebust, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 1, 2020
Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug ResponseSeungil Kim, Sarah Choung, Ren X Sun, et al.
Cell Reports Methods|April 14, 2023
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening dataAlvaro Köhn-Luque, Even Moa Myklebust, Dagim Shiferaw Tadele, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
JCO Clinical Cancer Informatics|February 14, 2019
Glioblastoma Recurrence and the Role of O<sup>6</sup>-Methylguanine-DNA Methyltransferase Promoter MethylationKatie Storey, Kevin Leder, Andrea Hawkins-Daarud, et al.
Molecular Pharmaceutics|October 15, 2011
Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancerShannon M Mumenthaler, Jasmine Foo, Kevin Leder, et al.
Plos Computational Biology|August 2, 2024
Understanding patient-derived tumor organoid growth through an integrated imaging and mathematical modeling frameworkEinar Bjarki Gunnarsson, Seungil Kim, Brandon Choi, et al.
RNA Biology|September 22, 2012
Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAsJingmin Shu, Zhilian Xia, Lihua Li, et al.
Cancer Informatics|August 6, 2015
The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer CellsShannon M Mumenthaler, Jasmine Foo, Nathan C Choi, et al.
Scientific Reports|July 26, 2016
A high-content image-based method for quantitatively studying context-dependent cell population dynamicsColleen M Garvey, Erin Spiller, Danika Lindsay, et al.
Plos Computational Biology|July 7, 2017
Combination therapeutics of Nilotinib and radiation in acute lymphoblastic leukemia as an effective method against drug-resistanceKamran Kaveh, Yutaka Takahashi, Michael A Farrar, et al.
Plos Computational Biology|March 6, 2024
Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening dataChenyu Wu, Einar Bjarki Gunnarsson, Even Moa Myklebust, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 1, 2020
Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug ResponseSeungil Kim, Sarah Choung, Ren X Sun, et al.
Cell Reports Methods|April 14, 2023
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening dataAlvaro Köhn-Luque, Even Moa Myklebust, Dagim Shiferaw Tadele, et al.
Pageof 5